Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C10H10NO4S2.Na |
| Molecular Weight | 295.31 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC(SC(=O)C1=CC=CS1)C(=O)NCC([O-])=O
InChI
InChIKey=LAKRODSFPQQVBB-UHFFFAOYSA-M
InChI=1S/C10H11NO4S2.Na/c1-6(9(14)11-5-8(12)13)17-10(15)7-3-2-4-16-7;/h2-4,6H,5H2,1H3,(H,11,14)(H,12,13);/q;+1/p-1
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C10H10NO4S2 |
| Molecular Weight | 272.321 |
| Charge | -1 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Stepronin is clinically used as an expectorant. It inhibits airway secretion in vitro by both decreasing Cl- secretion from epithelial cells and mucus glycoprotein secretion from submucosal glands. The mucolytic activity of stepronine does not involve the gastric mucous coating and that the drug does not exert adverse effects on the gastric mucosa. It is a new chemical immunosuppressant drug, which has the effect of preventing graft-versus-host-disease (GVHD) in a mouse model. The mechanism by which this compound acts as an immunosuppressant appears to be similar to cyclosporine A (CyA), although, in contrast to CyA, it is not toxic for animals and humans. Stepronin has an antiviral effect as well and is able to block, indirectly, the human immunodeficiency virus–1 (HIV-1) replication in mononuclear cells in vitro.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:1903018 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8177972 |
|||
Target ID: GO:0030321 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8177972 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:30:42 GMT 2025
by
admin
on
Mon Mar 31 18:30:42 GMT 2025
|
| Record UNII |
FR96Q1BI9E
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23691748
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
DTXSID90999373
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
SUB04570MIG
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
100000084978
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
78126-10-0
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
DBSALT002347
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
FR96Q1BI9E
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | |||
|
m10206
Created by
admin on Mon Mar 31 18:30:42 GMT 2025 , Edited by admin on Mon Mar 31 18:30:42 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |